The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The impact of cannabidiol (CBD) on aromatase inhibitor (AI)-associated musculoskeletal symptoms (AIMSS).
 
Nicole Margo Grogan Fleege
No Relationships to Disclose
 
Elise Miller
No Relationships to Disclose
 
Kelley M. Kidwell
Honoraria - Mallinckrodt
 
Kelly L. Scheu
No Relationships to Disclose
 
Kathleen A. Kemmer
Consulting or Advisory Role - FibroGen (I)
Research Funding - NCCN/Pfizer (I); Zenith Epigenetics (Inst)
 
Kevin Boehnke
Honoraria - Viatris
Research Funding - Journey Life Sciences (Inst); Tryp Therapeutics (Inst)
Other Relationship - Vireo Health
 
Norah Lynn Henry
Consulting or Advisory Role - AstraZeneca; Myovant Sciences
Research Funding - Blue Note Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Royalty from Up-to-Date